CMS Nominee McClellan Says He Will Testify On Rx Imports, But May Still Face Confirmation Delay
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Commissioner McClellan tells the Senate Finance Committee he will testify about drug reimportation after his nomination to head the Centers for Medicare & Medicaid Services is approved by the Senate. Sen. Dorgan, who has threatened to place a "hold" on the vote, is understood to be unwilling to wait.
You may also be interested in...
PhRMA Braces For Reimportation Fight; Job "Outsourcing" Is New Argument
Rep. Christensen warns PhRMA that the issue is becoming more difficult for Congress to fight. PhRMA's Holmer vows to press forward in case against importation.
PhRMA Braces For Reimportation Fight; Job "Outsourcing" Is New Argument
Rep. Christensen warns PhRMA that the issue is becoming more difficult for Congress to fight. PhRMA's Holmer vows to press forward in case against importation.